• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于诊断非线性混合效应模型的预测校正可视化预测检验。

Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models.

机构信息

Department of Pharmaceutical Biosciences, Uppsala University, Sweden.

出版信息

AAPS J. 2011 Jun;13(2):143-51. doi: 10.1208/s12248-011-9255-z. Epub 2011 Feb 8.

DOI:10.1208/s12248-011-9255-z
PMID:21302010
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3085712/
Abstract

Informative diagnostic tools are vital to the development of useful mixed-effects models. The Visual Predictive Check (VPC) is a popular tool for evaluating the performance of population PK and PKPD models. Ideally, a VPC will diagnose both the fixed and random effects in a mixed-effects model. In many cases, this can be done by comparing different percentiles of the observed data to percentiles of simulated data, generally grouped together within bins of an independent variable. However, the diagnostic value of a VPC can be hampered by binning across a large variability in dose and/or influential covariates. VPCs can also be misleading if applied to data following adaptive designs such as dose adjustments. The prediction-corrected VPC (pcVPC) offers a solution to these problems while retaining the visual interpretation of the traditional VPC. In a pcVPC, the variability coming from binning across independent variables is removed by normalizing the observed and simulated dependent variable based on the typical population prediction for the median independent variable in the bin. The principal benefit with the pcVPC has been explored by application to both simulated and real examples of PK and PKPD models. The investigated examples demonstrate that pcVPCs have an enhanced ability to diagnose model misspecification especially with respect to random effects models in a range of situations. The pcVPC was in contrast to traditional VPCs shown to be readily applicable to data from studies with a priori and/or a posteriori dose adaptations.

摘要

信息性诊断工具对于开发有用的混合效应模型至关重要。可视预测检查(VPC)是评估群体 PK 和 PKPD 模型性能的常用工具。理想情况下,VPC 将诊断混合效应模型中的固定效应和随机效应。在许多情况下,这可以通过将观察数据的不同分位数与模拟数据的分位数进行比较来实现,通常在自变量的箱内分组。然而,VPC 的诊断价值可能会受到剂量和/或有影响的协变量的大变异的箱分的阻碍。如果将 VPC 应用于自适应设计(例如剂量调整)后的数据,也可能会产生误导。预测校正 VPC(pcVPC)在保留传统 VPC 的视觉解释的同时,为这些问题提供了一种解决方案。在 pcVPC 中,通过根据箱中中位数自变量的典型人群预测,对观察到的和模拟的因变量进行归一化,消除了因自变量箱分引起的变异性。通过对 PK 和 PKPD 模型的模拟和真实示例的应用,已经探讨了 pcVPC 的主要优势。所研究的示例表明,pcVPC 具有增强的诊断模型指定错误的能力,尤其是在各种情况下的随机效应模型方面。与传统 VPC 相比,pcVPC 被证明易于应用于具有事先和/或事后剂量调整的研究的数据。

相似文献

1
Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models.用于诊断非线性混合效应模型的预测校正可视化预测检验。
AAPS J. 2011 Jun;13(2):143-51. doi: 10.1208/s12248-011-9255-z. Epub 2011 Feb 8.
2
The Reference-Corrected Visual Predictive Check: A More Intuitive Diagnostic for Non-Linear Mixed Effects Models.参考校正视觉预测检查:一种用于非线性混合效应模型的更直观诊断方法。
AAPS J. 2025 Apr 29;27(4):86. doi: 10.1208/s12248-025-01065-2.
3
Standardized visual predictive check versus visual predictive check for model evaluation.标准化视觉预测检查与模型评估的视觉预测检查。
J Clin Pharmacol. 2012 Jan;52(1):39-54. doi: 10.1177/0091270010390040. Epub 2011 Jan 21.
4
A Regression Approach to Visual Predictive Checks for Population Pharmacometric Models.基于回归的群体药代动力学模型可视化预测核查方法。
CPT Pharmacometrics Syst Pharmacol. 2018 Oct;7(10):678-686. doi: 10.1002/psp4.12319. Epub 2018 Sep 10.
5
[Comparison study of model evaluation methods: normalized prediction distribution errors vs. visual predictive check].模型评估方法的比较研究:标准化预测分布误差与可视化预测检查
Yao Xue Xue Bao. 2011 Sep;46(9):1123-31.
6
Visual Predictive Check in Models with Time-Varying Input Function.具有时变输入函数的模型中的可视化预测检查
AAPS J. 2015 Nov;17(6):1455-63. doi: 10.1208/s12248-015-9808-7. Epub 2015 Aug 12.
7
Development of visual predictive checks accounting for multimodal parameter distributions in mixture models.开发考虑混合模型中多峰参数分布的可视化预测检查。
J Pharmacokinet Pharmacodyn. 2019 Jun;46(3):241-250. doi: 10.1007/s10928-019-09632-9. Epub 2019 Apr 9.
8
Visual predictive check of longitudinal models and dropout.纵向模型和缺失值的可视化预测检查。
J Pharmacokinet Pharmacodyn. 2024 Dec;51(6):859-875. doi: 10.1007/s10928-024-09937-4. Epub 2024 Aug 18.
9
Extensions to the visual predictive check to facilitate model performance evaluation.视觉预测检查的扩展,以促进模型性能评估。
J Pharmacokinet Pharmacodyn. 2008 Apr;35(2):185-202. doi: 10.1007/s10928-007-9081-1. Epub 2008 Jan 16.
10
PFIM 4.0, an extended R program for design evaluation and optimization in nonlinear mixed-effect models.PFIM 4.0,一个用于非线性混合效应模型设计评估和优化的扩展 R 程序。
Comput Methods Programs Biomed. 2018 Mar;156:217-229. doi: 10.1016/j.cmpb.2018.01.008. Epub 2018 Jan 11.

引用本文的文献

1
AI-NLME: A New Artificial Intelligence-Driven Nonlinear Mixed Effect Modeling Approach for Analyzing Longitudinal Data in Randomized Placebo-Controlled Clinical Trials.AI-NLME:一种用于分析随机安慰剂对照临床试验中纵向数据的新型人工智能驱动的非线性混合效应建模方法。
Clin Transl Sci. 2025 Sep;18(9):e70345. doi: 10.1111/cts.70345.
2
Optimizing Early Ophthalmology Clinical Trials: Home OCT and Modeling Can Reduce Sample Size by 20% to 40.优化早期眼科临床试验:家庭光学相干断层扫描(OCT)和建模可将样本量减少20%至40%。
Transl Vis Sci Technol. 2025 Sep 2;14(9):2. doi: 10.1167/tvst.14.9.2.
3
Meropenem and piperacillin/tazobactam optimised dosing regimens for critically ill patients receiving renal replacement therapy.美罗培南和哌拉西林/他唑巴坦用于接受肾脏替代治疗的重症患者的优化给药方案。
Intensive Care Med. 2025 Aug 13. doi: 10.1007/s00134-025-08067-w.
4
Quantifying clinical and genetic factors influencing rate and severity of autosomal dominant tubulointerstitial kidney disease progression.量化影响常染色体显性遗传性肾小管间质性肾病进展速率和严重程度的临床及遗传因素。
J Pharmacokinet Pharmacodyn. 2025 Jul 24;52(4):41. doi: 10.1007/s10928-025-09989-0.
5
Population Pharmacokinetic and Pharmacokinetic-Pharmacodynamic Modeling of Serum M-Protein Response for Modakafusp Alfa in a Phase 1/2 Study of Patients With Relapsed or Refractory Multiple Myeloma.在复发或难治性多发性骨髓瘤患者的1/2期研究中,莫达卡福斯 Alfa血清M蛋白反应的群体药代动力学和药代动力学-药效学建模
Clin Transl Sci. 2025 Jul;18(7):e70296. doi: 10.1111/cts.70296.
6
Externally validated population pharmacokinetics of amikacin and evaluation of dosage regimen based on achieved serum concentrations in neonates.阿米卡星的外部验证群体药代动力学及基于新生儿血清浓度实现情况的给药方案评估。
Antimicrob Agents Chemother. 2025 Aug 6;69(8):e0081825. doi: 10.1128/aac.00818-25. Epub 2025 Jul 17.
7
Pirana and Integrated PMX Tools, a Workbench for NONMEM, NLME, pyDarwin, and RsNLME.皮拉纳与集成式群体药代动力学工具,一款用于NONMEM、非线性混合效应模型、pyDarwin和RsNLME的工作台。
CPT Pharmacometrics Syst Pharmacol. 2025 Aug;14(8):1298-1309. doi: 10.1002/psp4.70067. Epub 2025 Jul 4.
8
Population Pharmacokinetics and Exposure-Response Analysis of Benralizumab in Chinese Adults, Adolescents, and Pediatric Participants with Severe Eosinophilic Asthma.倍利珠单抗在中国患有重度嗜酸性粒细胞性哮喘的成人、青少年和儿童参与者中的群体药代动力学及暴露-反应分析。
Clin Pharmacokinet. 2025 Jun 23. doi: 10.1007/s40262-025-01538-9.
9
Population pharmacokinetic analyses for telavancin using data from healthy subjects and patients with infections.利用健康受试者和感染患者的数据进行替拉万星的群体药代动力学分析。
Antimicrob Agents Chemother. 2025 Jul 2;69(7):e0138224. doi: 10.1128/aac.01382-24. Epub 2025 Jun 12.
10
Population pharmacokinetic and exposure-response study of a novel anti-tuberculosis drug to inform its dosage design in phase III clinical trial.一种新型抗结核药物的群体药代动力学和暴露-反应研究,为其III期临床试验的剂量设计提供依据。
Eur J Pharm Sci. 2025 Sep 1;212:107160. doi: 10.1016/j.ejps.2025.107160. Epub 2025 Jun 8.

本文引用的文献

1
The future of drug development: advancing clinical trial design.药物研发的未来:推进临床试验设计。
Nat Rev Drug Discov. 2009 Dec;8(12):949-57. doi: 10.1038/nrd3025. Epub 2009 Oct 9.
2
Population pharmacokinetics of tacrolimus in pediatric hematopoietic stem cell transplant recipients: new initial dosage suggestions and a model-based dosage adjustment tool.他克莫司在儿科造血干细胞移植受者中的群体药代动力学:新的初始剂量建议和基于模型的剂量调整工具。
Ther Drug Monit. 2009 Aug;31(4):457-66. doi: 10.1097/FTD.0b013e3181aab02b.
3
Handling data below the limit of quantification in mixed effect models.在混合效应模型中处理低于定量限的数据。
AAPS J. 2009 Jun;11(2):371-80. doi: 10.1208/s12248-009-9112-5. Epub 2009 May 19.
4
Modeling and simulation of the time course of asenapine exposure response and dropout patterns in acute schizophrenia.急性精神分裂症中阿立哌唑暴露反应及脱落模式时间进程的建模与模拟
Clin Pharmacol Ther. 2009 Jul;86(1):84-91. doi: 10.1038/clpt.2009.44. Epub 2009 Apr 22.
5
Approaches to handling pharmacodynamic baseline responses.处理药效学基线反应的方法。
J Pharmacokinet Pharmacodyn. 2008 Jun;35(3):269-83. doi: 10.1007/s10928-008-9088-2. Epub 2008 Apr 30.
6
Computing normalised prediction distribution errors to evaluate nonlinear mixed-effect models: the npde add-on package for R.计算归一化预测分布误差以评估非线性混合效应模型:用于R的npde附加包。
Comput Methods Programs Biomed. 2008 May;90(2):154-66. doi: 10.1016/j.cmpb.2007.12.002. Epub 2008 Jan 22.
7
Extensions to the visual predictive check to facilitate model performance evaluation.视觉预测检查的扩展,以促进模型性能评估。
J Pharmacokinet Pharmacodyn. 2008 Apr;35(2):185-202. doi: 10.1007/s10928-007-9081-1. Epub 2008 Jan 16.
8
Diagnosing model diagnostics.诊断模型诊断
Clin Pharmacol Ther. 2007 Jul;82(1):17-20. doi: 10.1038/sj.clpt.6100241.
9
PsN-Toolkit--a collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM.PsN工具包——一组使用NONMEM进行非线性混合效应建模的计算机密集型统计方法。
Comput Methods Programs Biomed. 2005 Sep;79(3):241-57. doi: 10.1016/j.cmpb.2005.04.005.
10
Perl-speaks-NONMEM (PsN)--a Perl module for NONMEM related programming.Perl 语言的 NONMEM 工具(PsN)——一个用于 NONMEM 相关编程的 Perl 模块。
Comput Methods Programs Biomed. 2004 Aug;75(2):85-94. doi: 10.1016/j.cmpb.2003.11.003.